Brief: Cynata Therapeutics Received Human Research Ethics Committee And Research Governance Approvals From Central Adelaide Local Health Network
18/11/2021 01:50
Nov 18 (Reuters) - Cynata Therapeutics Ltd CYP.AX :
* RECEIVED HUMAN RESEARCH ETHICS COMMITTEE AND RESEARCH
GOVERNANCE
APPROVALS FROM CENTRAL ADELAIDE LOCAL HEALTH NETWORK
* APPROVALS RECEIVED FOR DIABETIC FOOT ULCERS CLINICAL
TRIAL
Source text for Eikon: ID:nASX4MX3mR
Further company coverage: CYP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cynata Therapeutics
See all newsBrief: Cynata Therapeutics Says Firm Commitments Received To Raise Further A$550,000 Via Placement
Brief: Cynata Therapeutics Enters Consultancy Agreement With LIR Bio Advisory
Brief: Cynata Therapeutics Establishes Share Sale Facility For Unmarketable Parcel Holders
Brief: Cynata Therapeutics Terminates Of At-The-Market Subscription Deed
Brief: Cynata Therapeutics Posts FY2026 Loss From Ordinary Activities After Tax A$9.1 Million